Efficient use of ultrasound therapy with or without diclofenac gel in relieving pain in facial and neck muscles.

The efficacy of phonophoresis over conventional ultrasound therapy for pain relief in patients with Myofascial Pain Syndrome-a randomized control trial - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/089291

Enrollment

Registered

2025-06-23

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M629- Disorder of muscle, unspecified

Interventions

Intervention1: Diclofenac diethylamine 1.16% gel that is applied topically over the affected site . : This gel is equivalent to diclofenac sodium IP 1%w/w available with the brand name of Voveran gel

Eligibility

Inclusion criteria

Inclusion criteria: Patients in age group of 18-60 years Patients who satisfy Laskins criteria for MPDS Patients not taking any medications /alternate therapy for MPDS

Exclusion criteria

Exclusion criteria: Pregnant and lactating women, those with pacemakers, diclofenac allergy, the pain of odontogenic origin, neuralgias, neuromuscular disorders, already treated with anti-inflammatory, muscle relaxant, and analgesic drugs, intraarticular temporomandibular joint disorders, jaw tumors, and trauma.

Design outcomes

Primary

Measure	Time frame
Improvement in mouth opening Reduction in tenderness on opening the mouth Reduction in individual muscle tenderness Reduction in individual muscle tendernessTimepoint: After 8 sessions spread over 8 days	—

Secondary

Measure	Time frame
nilTimepoint:	—

Countries

India

Contacts

Public ContactDr Richa Srivastava

DY Patil school of dentistry, Nerul, Navi Mumbai

mandavi.waghmare@dypatil.edu08108069665

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026